Tag Archives: Houston company testing drug to protect against COVID-19

HOUSTON, Texas (KTRK) — A Houston-based company was just given the green light to begin trial studies on a drug that could help protect against and treat coronavirus. The FDA recently approved Pulmotect to start a pair of phase two studies with their inhalant drug, PUL-042. The company created PUL-042 about five years ago with the mission to protect the …

Read More »